Sandoz and attorneys for the plaintiffs, "end-purchasers" including consumers who bought Sandoz drugs from pharmacies, did not immediately respond to requests for comment. The settlement period ...

"As the world's leading provider of generic antibiotics, our goal at Sandoz is to play a key role in overcoming this growing threat," he added. Sandoz' parent Novartis exited novel antibiotics R&D ...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesMEDIA RELEASEFY 2024 net sales[1] of USD 10.4 billion, up by 9%[2] in ...

Novo Nordisk plans to offer its Wegovy weight loss drug at a reduced cost of $499 per month for cash-paying customers in the ...

The pharmaceutical company Sandoz in Kundl is further expanding its production of antibiotics. The capacity is now around 240 ...

Like rivals Teva Pharmaceutical Industries Ltd. and Viatris Inc., Sandoz copies branded drugs once they lose patent protection, which leads to reduced costs. It manufactures those products largely ...

and investments in the Sandoz antibiotics network in Kundl, Austria. Free cash flow was USD 98 million compared to negative USD 234 million in the prior year. The improvement was mainly due to net ...